Betmiga 25mg-NE (Mirabegron Tablet) 25mg

Betmiga 25mg-NE (Mirabegron) is a prescription tablet used for overactive bladder symptoms like frequent urination. This extended-release formulation helps manage urgency and incontinence. Store at room temperature and keep out of reach of children. Always follow healthcare provider guidance.

Strength

25mg

Pack Size

90s

Storage

Ambient

Manufacturer / TM Owner

ASTELLAS PHARMA

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Betmiga 25mg-NE (Mirabegron) is commonly used to treat symptoms of overactive bladder, including frequent urination, urgency, and urge incontinence. It works by relaxing the bladder muscles to reduce sudden urges and improve bladder control. This medication is often prescribed when lifestyle changes alone are insufficient.

Side Effects

Betmiga 25mg-NE (Mirabegron) may help reduce sudden urges to urinate and the number of times you need to go. Some users report fewer nighttime bathroom trips and improved bladder control. Effects can vary, and it may take time to notice the full benefits.

Precautions & Warnings

Keep Betmiga 25mg-NE (Mirabegron) in a cool, dry place away from direct sunlight. Store at room temperature and ensure it is not accessible to children or pets. Do not use if the packaging is damaged or the tablets appear altered. Consult a healthcare provider before starting or stopping this medication.

Avoid Interactions

Betmiga 25mg-NE (Mirabegron) may interact with other medications, including certain antidepressants, antifungals, and heart rhythm drugs. Alcohol and grapefruit products may also affect how this medication works. Always inform your healthcare provider about all medications and supplements you are taking.

Frequently Asked Questions

Betmiga 25mg (Mirabegron) is used to treat symptoms of overactive bladder, such as frequent urination and urgency.

Store Betmiga 25mg at room temperature in a dry place, away from children and direct sunlight.

Consult your healthcare provider before combining Betmiga with other medications to avoid potential interactions.

Effects may vary; some users notice improvements within a few weeks, while others may take longer.

No, Betmiga is a prescription medication and requires a healthcare provider's approval.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.